Densitometric Analysis of c/EBPε and MPO in Human Hematopoietic Cell Lines
Cell Type . | Cell Line . | C/EBPε/ . | MPO/ . |
---|---|---|---|
. | . | β-Actin . | β-Actin . |
Promyelocyte | NB4 | 2.5 | 1.3 |
Myeloblast* | GFD8 | 2.26 | 0.16 |
Late myeloblast | HL-60 | 2.24 | 1.39 |
Myelomonoblast | THP1 | 0.42 | 0.2 |
Myeloblast* | MDS92 | 0.33 | 0.87 |
Early myeloblast | KCL22 | 0.25 | 0 |
Myelomonoblast | U937 | 0.24 | 0 |
Nl granulocyte | — | 0.19 | 0.54 |
Early myeloblast | ML-1 | 0.18 | 1.48 |
Early myeloblast* | TF-1 | 0.06 | 0 |
Early myeloblast* | GM150 | 0.05 | 0 |
Early myeloblast* | AML1 | 0.05 | 1.15 |
Early myeloblast | KG1 | 0.04 | 0 |
Nl macrophage | — | 0.04 | 0 |
Erythroblast | HEL | 0 | 0 |
Erythroblast | K562 | 0 | 0 |
Megakaryoblast | MEGA1 | 0 | 0 |
Basophil precursor | KU812 | 0 | 0 |
Cell Type . | Cell Line . | C/EBPε/ . | MPO/ . |
---|---|---|---|
. | . | β-Actin . | β-Actin . |
Promyelocyte | NB4 | 2.5 | 1.3 |
Myeloblast* | GFD8 | 2.26 | 0.16 |
Late myeloblast | HL-60 | 2.24 | 1.39 |
Myelomonoblast | THP1 | 0.42 | 0.2 |
Myeloblast* | MDS92 | 0.33 | 0.87 |
Early myeloblast | KCL22 | 0.25 | 0 |
Myelomonoblast | U937 | 0.24 | 0 |
Nl granulocyte | — | 0.19 | 0.54 |
Early myeloblast | ML-1 | 0.18 | 1.48 |
Early myeloblast* | TF-1 | 0.06 | 0 |
Early myeloblast* | GM150 | 0.05 | 0 |
Early myeloblast* | AML1 | 0.05 | 1.15 |
Early myeloblast | KG1 | 0.04 | 0 |
Nl macrophage | — | 0.04 | 0 |
Erythroblast | HEL | 0 | 0 |
Erythroblast | K562 | 0 | 0 |
Megakaryoblast | MEGA1 | 0 | 0 |
Basophil precursor | KU812 | 0 | 0 |
Densitometry was performed for all the samples and ratios were calculated between hybridization intensity of β-actin and either C/EBPε or MPO. Most samples were analyzed several times with very similar results.
Abbreviation: Nl, normal.
Growth factor-dependent cell lines.